Sign in
CAMP Stock Price, Chart, Stats & News
CAMP4 Therapeutics Corporation
Save
CAMP4 Therapeutics Corporation (CAMP) does not currently pay a dividend.
83.26M
Market cap
–
Current P/E
–
Forward P/E
CAMP chart
Fundamentals
Gross margin | 77.47% |
Operating margin | -1488.31% |
Pretax margin | -2298.54% |
Net margin | -2298.54% |
Effective tax rate | – |
ROA | -68.25% |
ROE | -162.49% |
D/E | 0.04x |
Interest coverage ratio | – |
CAMP valuation
P/E | – |
P/S | 26.17x |
P/B | 4.69x |
P/CF | -7.57x |
P/FCF | -3.07x |
P/OCF | -7.57x |
PEG | 0.69x |
EV multiple | -3.80x |
About
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Similar securities
Based on sector and market capitalization
Report issue